2022年
- 1: Irie F.
Commentary on the Risk Assessment of Lead by the Food Safety Commission of Japan.
Food Saf (Tokyo). 2022 Sep 23;10(3):102-111. doi: 10.14252/foodsafetyfscj.D-22-00007. PMID: 36237398; PMCID: PMC9509536. - 2: Yasuhiko Y, Ishigami M, Machino S, Fujii T, Aoki M, Irie F, Kanda Y, Yoshida M.
Comparison of the lower limit of benchmark dose confidence interval with no- observed-adverse-effect level by applying four different software for tumorigenicity testing of pesticides in Japan.
Regul Toxicol Pharmacol. 2022 Aug;133:105201. doi: 10.1016/j.yrtph.2022.105201. Epub 2022 Jun 9. PMID: 35691450. - 3: Ren N, Ogata S, Kiyoshige E, Nishimura K, Nishimura A, Matsuo R, Kitazono T, Higashi T, Ogasawara K, Iihara K; Close The Gap-Stroke, J-ASPECT Study Collaborators*.
Associations Between Adherence to Evidence-Based, Stroke Quality Indicators and Outcomes of Acute Reperfusion Therapy.
Stroke. 2022 Nov;53(11):3359-3368. doi: 10.1161/STROKEAHA.121.038483. Epub 2022 Aug 16. PMID: 35971841; PMCID: PMC9586826. - 4: Okuda T, Arimura K, Matsuo R, Tokunaga S, Hara K, Yamaguchi S, Yoshida H, Kurogi R, Kameda K, Ito O, Tsumoto T, Iihara K, Mizokami T, Uwatoko T, Nishimura A, Iwaki K, Mizoguchi M; QNET investigators.
Efficacy of combined use of a stent retriever and aspiration catheter in mechanical thrombectomy for acute ischemic stroke.
J Neurointerv Surg. 2022 Sep;14(9):892-897. doi: 10.1136/neurintsurg-2021-017837. Epub 2021 Sep 20. PMID: 34544828. - 5: Li Y, Babazono A, Jamal A, Liu N, Fujita T, Zhao R, Maeno Y, Su Y, Liang L, Yao L.
The impact of lifestyle guidance intervention on health outcomes among Japanese middle-aged population with metabolic syndrome: A regression discontinuity study.
Soc Sci Med. 2022 Dec;314:115468. doi: 10.1016/j.socscimed.2022.115468. Epub 2022 Oct 26. PMID: 36327638. - 6: Kim SA, Babazono A, Fujita T, Jamal A.
Impact of Income Disparity on Utilization of Home-Based Care Services Among Older Adults in Japan: A Retrospective Cohort Study.
Popul Health Manag. 2022 Oct;25(5):639-650. doi: 10.1089/pop.2022.0110. Epub 2022 Aug 30. PMID: 36040370. - 7: Liu N, Babazono A, Ishihara R, Li Y, Jamal A, Kim SA, Matsuda S.
Association between care rehabilitation and the risk of fracture hospitalization in people with Parkinson’s disease.
Geriatr Gerontol Int. 2022 Aug;22(8):628-634. doi: 10.1111/ggi.14428. Epub 2022 Jul 1. PMID: 35777740. - 8: Ishihara R, Babazono A, Liu N, Yamao R.
Impact of Income and Industry on New-Onset Diabetes among Employees: A Retrospective Cohort Study.
Int J Environ Res Public Health. 2022 Jan 19;19(3):1090. doi: 10.3390/ijerph19031090. PMID: 35162114; PMCID: PMC8834605. - 9: Narita I, Hayashi T, Maruyama S, Masaki T, Nangaku M, Nishino T, Sato H, Sofue T, Wada T, Imai E, Iwasaki M, Mizuno K, Hase H, Kamouchi M, Yamamoto H, Kagimura T, Tanabe K, Kato H, Wada T, Usui T, Akizawa T, Hirakata H, Tsubakihara Y.
Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis- dependent CKD patients: The BRIGHTEN study.
PLoS One. 2022 Nov 29;17(11):e0277921. doi: 10.1371/journal.pone.0277921. PMID: 36445882; PMCID: PMC9707758. - 10: Mishra A, Malik R, Hachiya T, Jürgenson T, Namba S, Posner DC, Kamanu FK, Koido M, Le Grand Q, Shi M, He Y, Georgakis MK, Caro I, Krebs K, Liaw YC, Vaura FC, Lin K, Winsvold BS, Srinivasasainagendra V, Parodi L, Bae HJ, Chauhan G, Chong MR, Tomppo L, Akinyemi R, Roshchupkin GV, Habib N, Jee YH, Thomassen JQ, Abedi V, Cárcel-Márquez J, Nygaard M, Leonard HL, Yang C, Yonova-Doing E, Knol MJ, Lewis AJ, Judy RL, Ago T, Amouyel P, Armstrong ND, Bakker MK, Bartz TM, Bennett DA, Bis JC, Bordes C, Børte S, Cain A, Ridker PM, Cho K, Chen Z, Cruchaga C, Cole JW, de Jager PL, de Cid R, Endres M, Ferreira LE, Geerlings MI, Gasca NC, Gudnason V, Hata J, He J, Heath AK, Ho YL, Havulinna AS, Hopewell JC, Hyacinth HI, Inouye M, Jacob MA, Jeon CE, Jern C, Kamouchi M, Keene KL, Kitazono T, Kittner SJ, Konuma T, Kumar A, Lacaze P, Launer LJ, Lee KJ, Lepik K, Li J, Li L, Manichaikul A, Markus HS, Marston NA, Meitinger T, Mitchell BD, Montellano FA, Morisaki T, Mosley TH, Nalls MA, Nordestgaard BG, O’Donnell MJ, Okada Y, Onland-Moret NC, Ovbiagele B, Peters A, Psaty BM, Rich SS, Rosand J, Sabatine MS, Sacco RL, Saleheen D, Sandset EC, Salomaa V, Sargurupremraj M, Sasaki M, Satizabal CL, Schmidt CO, Shimizu A, Smith NL, Sloane KL, Sutoh Y, Sun YV, Tanno K, Tiedt S, Tatlisumak T, Torres-Aguila NP, Tiwari HK, Trégouët DA, Trompet S, Tuladhar AM, Tybjærg-Hansen A, van Vugt M, Vibo R, Verma SS, Wiggins KL, Wennberg P, Woo D, Wilson PWF, Xu H, Yang Q, Yoon K; COMPASS Consortium; INVENT Consortium; Dutch Parelsnoer Initiative (PSI) Cerebrovascular Disease Study Group; Estonian Biobank; PRECISE4Q Consortium; FinnGen Consortium; NINDS Stroke Genetics Network (SiGN); MEGASTROKE Consortium; SIREN Consortium; China Kadoorie Biobank Collaborative Group; VA Million Veteran Program; International Stroke Genetics Consortium (ISGC); Biobank Japan; CHARGE Consortium; GIGASTROKE Consortium; Millwood IY, Gieger C, Ninomiya T, Grabe HJ, Jukema JW, Rissanen IL, Strbian D, Kim YJ, Chen PH, Mayerhofer E, Howson JMM, Irvin MR, Adams H, Wassertheil-Smoller S, Christensen K, Ikram MA, Rundek T, Worrall BB, Lathrop GM, Riaz M, Simonsick EM, Kõrv J, França PHC, Zand R, Prasad K, Frikke-Schmidt R, de Leeuw FE, Liman T, Haeusler KG, Ruigrok YM, Heuschmann PU, Longstreth WT, Jung KJ, Bastarache L, Paré G, Damrauer SM, Chasman DI, Rotter JI, Anderson CD, Zwart JA, Niiranen TJ, Fornage M, Liaw YP, Seshadri S, Fernández-Cadenas I, Walters RG, Ruff CT, Owolabi MO, Huffman JE, Milani L, Kamatani Y, Dichgans M, Debette S.
Stroke genetics informs drug discovery and risk prediction across ancestries.
Nature. 2022 Nov;611(7934):115-123. doi: 10.1038/s41586-022-05165-3. Epub 2022 Sep 30. Erratum in: Nature. 2022 Dec;612(7938):E7. PMID: 36180795; PMCID: PMC9524349. - 11: Ohya Y, Matsuo R, Sato N, Irie F, Nakamura K, Wakisaka Y, Ago T, Kamouchi M, Kitazono T; Investigators for Fukuoka Stroke Registry.
Causes of ischemic stroke in young adults versus non-young adults: A multicenter hospital-based observational study.
PLoS One. 2022 Jul 13;17(7):e0268481. doi: 10.1371/journal.pone.0268481. PMID: 35830430; PMCID: PMC9278748. - 12: Kitazono T, Kamouchi M, Matsumaru Y, Nakamura M, Umemura K, Matsuo H, Koyama N, Tsutsumi J, Kimura K.
Efficacy and Safety of Prasugrel vs Clopidogrel in Thrombotic Stroke Patients With Risk Factors for Ischemic Stroke Recurrence: A Double-blind, Phase III Study (PRASTRO-III).
J Atheroscler Thromb. 2023 Mar 1;30(3):222-236. doi: 10.5551/jat.63473. Epub 2022 May 21. PMID: 35599000; PMCID: PMC9981351. - 13: Fujita T, Babazono A, Jiang P, Jamal A, Li Y.
Cost-effectiveness analysis of treatment with varenicline for nicotine dependence compared with smoking cessation without pharmacotherapy in the real world.
Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):187-195. doi: 10.1002/pds.5359. Epub 2021 Sep 25. PMID: 34529297. - 14: Fukuda K, Matsuo R, Kamouchi M, Kiyuna F, Sato N, Nakamura K, Hata J, Wakisaka Y, Ago T, Imaizumi T, Kai H, Kitazono T; FSR Investigators.
Day-by-Day Blood Pressure Variability in the Subacute Stage of Ischemic Stroke and Long- Term Recurrence.
Stroke. 2022 Jan;53(1):70-78. doi: 10.1161/STROKEAHA.120.033751. Epub 2021 Sep 9. PMID: 34496621. - 15: Li Y, Babazono A, Ohmori T, Jamal A, Yoshida S, Kim SA, Fujita T, Liu N.
Health Inequality Among Older Adults with Percutaneous Coronary Intervention and Universal Health Coverage in Japan.
Popul Health Manag. 2022 Feb;25(1):23-30. doi: 10.1089/pop.2021.0070. Epub 2021 Jun 1. PMID: 34076535. - 16: Li Y, Babazono A, Jamal A, Jiang P, Fujita T.
Cost-Sharing Effects on Hospital Service Utilization Among Older People in Fukuoka Prefecture, Japan.
Int J Health Policy Manag. 2022 Apr 1;11(4):489-497. doi: 10.34172/ijhpm.2020.190. PMID: 33059428; PMCID: PMC9309955. - 17: Moriyama S, Hieda M, Kisanuki M, Kawano S, Yokoyama T, Fukata M, Kusaba H, Maruyama T, Baba E, Akashi K, Fukuda H.
Effect of renin-angiotensin system inhibitors in patients with cancer treated with anti-VEGF therapy.
Open Heart. 2022 Dec;9(2):e002135. doi: 10.1136/openhrt-2022-002135. PMID: 36600585; PMCID: PMC9743396. - 18: Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.
Effectiveness of a Third Dose of COVID-19 mRNA Vaccine During the Omicron BA.1- and BA.2-Predominant Periods in Japan: The VENUS Study.
Open Forum Infect Dis. 2022 Nov 24;9(12):ofac636. doi: 10.1093/ofid/ofac636. PMID: 36589480; PMCID: PMC9792082. - 19: Shoji T, Muto R, Fukuda H, Muraki Y, Kawata K, Akazawa M.
Cost and healthcare utilization of methicillin-resistant Staphylococcus aureus bacteremia estimated from linked antimicrobial resistance surveillance and hospital claims data in Japan.
Antimicrob Steward Healthc Epidemiol. 2022 Aug 30;2(1):e147. doi: 10.1017/ash.2022.280. PMID: 36483379; PMCID: PMC9726553. - 20: Nishimura N, Fukuda H.
Risk of cardiovascular events leading to hospitalisation after Streptococcus pneumoniae infection: a retrospective cohort LIFE Study.
BMJ Open. 2022 Nov 4;12(11):e059713. doi: 10.1136/bmjopen-2021-059713. PMID: 36332949; PMCID: PMC9639073. - 21: Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.
Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
Int J Infect Dis. 2022 Dec;125:58-60. doi: 10.1016/j.ijid.2022.10.001. Epub 2022 Oct 8. PMID: 36220547; PMCID: PMC9547653. - 22: Fukuda H, Maeda M, Murata F, Murata Y.
Anti-Dementia Drug Persistence Following Donepezil Initiation Among Alzheimer’s Disease Patients in Japan: LIFE Study.
J Alzheimers Dis. 2022;90(3):1177-1186. doi: 10.3233/JAD-220200. PMID: 36213993; PMCID: PMC9741733. - 23: Ishiguro C, Mimura W, Murata F, Fukuda H.
Development and application of a Japanese vaccine database for comparative assessments in the post-authorization phase: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
Vaccine. 2022 Oct 6;40(42):6179-6186. doi: 10.1016/j.vaccine.2022.08.069. Epub 2022 Sep 9. PMID: 36096969. - 24: Mimura W, Ishiguro C, Fukuda H.
Influenza vaccine effectiveness against hospitalization during the 2018/2019 season among older persons aged ≥ 75 years in Japan: The LIFE-VENUS Study.
Vaccine. 2022 Aug 12;40(34):5023-5029. doi: 10.1016/j.vaccine.2022.07.002. Epub 2022 Jul 15. PMID: 35851488. - 25: Murata F, Maeda M, Ishiguro C, Fukuda H.
Acute and delayed psychiatric sequelae among patients hospitalised with COVID-19: a cohort study using LIFE study data.
Gen Psychiatr. 2022 Jun 20;35(3):e100802. doi: 10.1136/gpsych-2022-100802. PMID: 35846486; PMCID: PMC9214348. - 26: Tani N, Fukuda H.
Medical visits and health-care expenditures of patients attending orthopedic clinics during the COVID-19 pandemic in Japan: LIFE Study.
Int J Qual Health Care. 2022 Jul 9;34(3):mzac056. doi: 10.1093/intqhc/mzac056. PMID: 35808994; PMCID: PMC9278191. - 27: Shoji T, Sato N, Fukuda H, Muraki Y, Kawata K, Akazawa M.
Clinical Implication of the Relationship between Antimicrobial Resistance and Infection Control Activities in Japanese Hospitals: A Principal Component Analysis-Based Cluster Analysis.
Antibiotics (Basel). 2022 Feb 10;11(2):229. doi: 10.3390/antibiotics11020229. PMID: 35203831; PMCID: PMC8868447. - 28: Fukuda H, Onizuka H, Nishimura N, Kiyohara K.
Risk factors for pneumococcal disease in persons with chronic medical conditions: Results from the LIFE Study.
Int J Infect Dis. 2022 Mar;116:216-222. doi: 10.1016/j.ijid.2021.12.365. Epub 2022 Jan 2. PMID: 34986403. - 29: Ono R, Uchida K, Nakatsuka K, Megumi M, Fukuda H.
Economic Status and Mortality in Patients with Alzheimer’s Disease in Japan: The Longevity Improvement and Fair Evidence Study.
J Am Med Dir Assoc. 2022 Jan;23(1):161-164. doi: 10.1016/j.jamda.2021.08.025. Epub 2021 Sep 15. PMID: 34534490.